Key takeaway: During the Q4 and FY26 earnings conference call, management reported a strong performance with Q4 revenue from operations at ₹149.23 crores, a 57% increase year-on-year. EBITDA for the quarter was ₹21.41 crores, with a margin of 14.35%, reflecting a significant year-on-year expansion. For FY26, total revenue reached ₹500.95 crores, a 36% growth from FY25, with profit after tax at ₹48.13 crores, up 128%. Management noted challenges from geopolitical factors affecting costs but indicated a partial price pass-through had been secured. The ongoing capacity expansion was discussed, with Phase I contributing positively and Phase II facing delays. Management highlighted a diversified customer base and product portfolio, with a focus on continued growth and operational momentum. They expressed confidence in the resilience of the business despite external challenges.

Key takeaway: The investor presentation for NGL Fine-Chem Limited for Q4 and FY26 reported strong performance characterized by significant sales growth driven by volume expansion. Management noted this marked the third consecutive quarter of robust volume growth across the product portfolio and geographic markets. The ongoing capital expenditure program's Phase I contributed positively to operations, allowing the company to service higher volumes. However, management acknowledged challenges such as increased freight costs and raw material prices due to geopolitical volatility, which affected margins. The commissioning of Phase II of the capex program was delayed to early Q2FY27. Despite these challenges, management highlighted successful partial price pass-throughs to customers and expressed confidence in the business's recovery trajectory and future growth potential. Financial metrics showed a year-on-year revenue increase of 36.03% and a profit after tax increase of 127.83%.

Key takeaway: In the investor presentation for Q3 and 9M FY26, NGL Fine-Chem Limited reported a strong performance across key financial and operational metrics. Management noted modest revenue growth driven by higher volumes, while price realizations remained stable. Profitability improved significantly due to easing raw material costs and operational efficiencies. Demand conditions were described as firm across major markets, with healthy traction noted in various geographies and customer segments. The ongoing capital expenditure program is on track, with Phase II commissioning scheduled for Q1FY27, and total investment revised to approximately ₹210 crore. Management highlighted substantial progress in regulatory filings to support future growth, with multiple approvals received. The presentation included detailed financial metrics, showing increases in revenue, EBITDA, and profit after tax compared to previous periods.